BG107067A - Прозводни на 1н-имидазопиридин - Google Patents

Прозводни на 1н-имидазопиридин Download PDF

Info

Publication number
BG107067A
BG107067A BG107067A BG10706702A BG107067A BG 107067 A BG107067 A BG 107067A BG 107067 A BG107067 A BG 107067A BG 10706702 A BG10706702 A BG 10706702A BG 107067 A BG107067 A BG 107067A
Authority
BG
Bulgaria
Prior art keywords
group
substituted
ethyl
calculated
found
Prior art date
Application number
BG107067A
Other languages
Bulgarian (bg)
English (en)
Inventor
Hideo Kato
Jun Sakaguchi
Tomoyuki Izumi
Ken-Ichi Kato
Original Assignee
Hokuriku Seiyaku Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Seiyaku Co., Ltd filed Critical Hokuriku Seiyaku Co., Ltd
Publication of BG107067A publication Critical patent/BG107067A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG107067A 2000-02-09 2002-09-05 Прозводни на 1н-имидазопиридин BG107067A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000031270 2000-02-09
JP2000277507 2000-09-13
PCT/JP2001/000816 WO2001058900A1 (fr) 2000-02-09 2001-02-06 Derives de 1h-imidazopyridine

Publications (1)

Publication Number Publication Date
BG107067A true BG107067A (bg) 2003-09-30

Family

ID=26585077

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107067A BG107067A (bg) 2000-02-09 2002-09-05 Прозводни на 1н-имидазопиридин

Country Status (16)

Country Link
US (1) US20040054182A1 (fr)
EP (1) EP1256582A1 (fr)
KR (1) KR20020073211A (fr)
CN (1) CN1422269A (fr)
AU (1) AU2001230584A1 (fr)
BG (1) BG107067A (fr)
BR (1) BR0108303A (fr)
CA (1) CA2399136A1 (fr)
CZ (1) CZ20022626A3 (fr)
HU (1) HUP0204474A3 (fr)
IL (1) IL150841A0 (fr)
MX (1) MXPA02007525A (fr)
NO (1) NO20023750L (fr)
PL (1) PL355866A1 (fr)
SK (1) SK11202002A3 (fr)
WO (1) WO2001058900A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1474425E (pt) 2002-01-07 2006-09-29 Eisai Co Ltd Desazapurinas e sua utilizacao
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
AU2003254221A1 (en) 2002-07-26 2004-02-16 Biogal Gyogyszergyar Rt. Preparation of 1h-imidazo (4,5-c) quinolin-4-amines via novel 1h-imidazo (4,5-c) quinolin-4-cyano and 1h-imidazo (4,5-c) quinolin-4-carboxamide intermediates
BRPI0406761A (pt) 2003-01-14 2005-12-20 Arena Pharm Inc Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia
CA2517655A1 (fr) * 2003-03-07 2004-09-23 3M Innovative Properties Company 1-amino 1h-imidazoquinolines
EP1602655A4 (fr) 2003-03-07 2010-06-09 Kowa Co Derive benzofurane
US7163947B2 (en) 2003-03-07 2007-01-16 3M Innovative Properties Company 1-Amino 1H-imidazoquinolines
US7648997B2 (en) 2003-08-12 2010-01-19 Coley Pharmaceutical Group, Inc. Hydroxylamine substituted imidazoquinolines
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
US20050054665A1 (en) 2003-09-05 2005-03-10 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
BRPI0414856A (pt) 2003-10-03 2006-11-21 3M Innovative Properties Co imidazoquinolinas alcóxi-substituìdas
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
US7897767B2 (en) 2003-11-14 2011-03-01 3M Innovative Properties Company Oxime substituted imidazoquinolines
PL1687305T3 (pl) * 2003-11-21 2008-12-31 Novartis Ag Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych
AR046845A1 (es) * 2003-11-21 2005-12-28 Novartis Ag Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
KR101130928B1 (ko) 2003-11-25 2012-04-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 치환된 이미다조 고리 시스템 및 방법
EP1701955A1 (fr) 2003-12-29 2006-09-20 3M Innovative Properties Company Imidazoquinolines a substitution arylalcenyle et arylalkynyle
WO2005066169A2 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
DK1765310T3 (en) 2004-05-28 2016-01-11 Oryxe MIXING for transdermal delivery of LAV AND HØJMOLEKYLVÆGTFORBINDELSER
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (fr) 2004-06-18 2006-06-22 3M Innovative Properties Company Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
WO2006038923A2 (fr) 2004-06-18 2006-04-13 3M Innovative Properties Company Imidazonaphthyridines substituees par aryle
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
WO2007044050A2 (fr) 2005-02-04 2007-04-19 Bristol-Myers Squibb Company Composés tricycliques basés sur la 1h-imidazo[4,5-d]thiéno[3,2-b]pyridine et préparations pharmaceutiques les incluant
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
WO2006086634A2 (fr) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ，インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
JP2008535831A (ja) * 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレーテッド 環閉鎖および関連する方法および中間体
EP1869043A2 (fr) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines et analogues associes
EA014244B1 (ru) * 2005-09-23 2010-10-29 Коли Фармасьютикал Груп, Инк. СПОСОБ ПОЛУЧЕНИЯ 1-Н-ИМИДАЗО[4,5-c]ПИРИДИНОВ И ИХ АНАЛОГОВ
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
AU2011305525B2 (en) 2010-09-22 2016-08-18 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
WO2017048807A1 (fr) 2015-09-17 2017-03-23 Jrx Biotechnology, Inc. Approches pour améliorer l'hydratation ou l'humidification de la peau
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
ES2910083T3 (es) * 2017-03-10 2022-05-11 Pfizer Derivados de imidazo[4,5-c]quinolina cíclicos sustituidos

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT998979B (it) * 1973-10-26 1976-02-20 Snam Progetti Processo per la preparazione di chelati di uranio iv
US4293547A (en) * 1980-08-25 1981-10-06 The Upjohn Company Method of treating malaria
US6001355A (en) * 1982-12-14 1999-12-14 Dowdle; Eugene Bernard Davey Pro-tPA for the treatment of thrombosis, embolism and related conditions
DE3665609D1 (en) * 1985-05-28 1989-10-19 Sumitomo Chemical Co Recovery of metals adsorbed on chelating agents
GB8601421D0 (en) * 1986-01-21 1986-02-26 Welding Inst Charged particle beam generator
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5175296A (en) * 1991-03-01 1992-12-29 Minnesota Mining And Manufacturing Company Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
US5243041A (en) * 1991-08-22 1993-09-07 Fernandez Pol Jose A DNA vector with isolated CDNA gene encoding metallopanstimulin
US6140466A (en) * 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5854215A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals Incorporated Modulators of β-amyloid peptide aggregation
US6127393A (en) * 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US5955287A (en) * 1995-12-29 1999-09-21 Fernandez-Pol; Jose Alberto Method of determining level of biological substances elevated in the presence of cancer and other neoplasms
US5668016A (en) * 1995-12-29 1997-09-16 Fernandez-Pol; Jose Alberto Method of preparing and activating samples for radioimmunoassay and other test
CN1114407C (zh) * 1996-08-13 2003-07-16 P·N·吉罗莱马托斯股份有限公司 螯合剂碘氯羟喹在制备用于治疗早老性痴呆的药物组合物中的用途
JP2000119271A (ja) * 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体

Also Published As

Publication number Publication date
CN1422269A (zh) 2003-06-04
KR20020073211A (ko) 2002-09-19
CA2399136A1 (fr) 2001-08-16
MXPA02007525A (es) 2002-12-13
CZ20022626A3 (cs) 2003-02-12
WO2001058900A1 (fr) 2001-08-16
AU2001230584A1 (en) 2001-08-20
BR0108303A (pt) 2003-03-05
IL150841A0 (en) 2003-02-12
US20040054182A1 (en) 2004-03-18
NO20023750D0 (no) 2002-08-08
HUP0204474A3 (en) 2004-07-28
HUP0204474A2 (hu) 2003-04-28
SK11202002A3 (sk) 2003-03-04
EP1256582A1 (fr) 2002-11-13
NO20023750L (no) 2002-10-07
PL355866A1 (en) 2004-05-31

Similar Documents

Publication Publication Date Title
BG107067A (bg) Прозводни на 1н-имидазопиридин
KR100555014B1 (ko) 질소 함유 오원환 화합물
US8309571B2 (en) Heterobicyclic compounds useful as kinase inhibitors
EP2927224B1 (fr) Antagonistes du récepteur LPA
US7700591B2 (en) Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
TW202128653A (zh) 作為parp7抑制劑的嗒酮
AU4333299A (en) Quinazolinone inhibitors of cgmp phosphodiesterase
WO2000009506A1 (fr) Derives de 1h-imidazopyridine
WO2008060621A2 (fr) Aminopyrrolidines utilisés en tant qu'antagonistes du récepteur de la chimiokine
AU2007264791A1 (en) Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use
EP2731949A2 (fr) 2-pyridylimidazoles substitués utilisés comme inhibiteurs d'alk5 et/ou d'alk4
WO2003055447A2 (fr) Composes d'acridone heterocyclique inhibiteurs d'enzyme impdh
WO2014014874A1 (fr) Dérivés de pyrazole inhibant la production de leucotriène
KR20100049698A (ko) 바이사이클 피리미디논 및 그 용도
TW201002685A (en) Heterocyclic compound and use thereof
CN111886233B (zh) ***酮衍生物或其盐以及包含其的药物组合物
JPWO2005051949A1 (ja) 新規縮合イミダゾール誘導体
US10815222B2 (en) Compounds for use in the treatment of kinetoplastid infection
JP2023529884A (ja) コラーゲン１翻訳阻害剤及びその使用方法
US20150018333A1 (en) Inhibitors of leukotriene production
CA3199333A1 (fr) Modulateurs de traduction d'arnm c-myc et leurs utilisations dans le traitement du cancer
JP2002047287A (ja) 芳香族誘導体
JP2003002890A (ja) １ｈ−イミダゾピリジン誘導体
JP2002161095A (ja) １ｈ−イミダゾピリジン誘導体